BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 35954176)

  • 1. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention.
    Holjencin C; Jakymiw A
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in miRNA Delivery Systems.
    Dasgupta I; Chatterjee A
    Methods Protoc; 2021 Jan; 4(1):. PubMed ID: 33498244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics.
    Tyagi N; Arora S; Deshmukh SK; Singh S; Marimuthu S; Singh AP
    J Biomed Nanotechnol; 2016 Jan; 12(1):28-42. PubMed ID: 27301170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.
    Schachner-Nedherer AL; Werzer O; Kornmueller K; Prassl R; Zimmer A
    Int J Nanomedicine; 2019; 14():7795-7808. PubMed ID: 31576124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in nonviral vectors for gene delivery.
    Guo X; Huang L
    Acc Chem Res; 2012 Jul; 45(7):971-9. PubMed ID: 21870813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies.
    Forterre A; Komuro H; Aminova S; Harada M
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral based miR delivery and recent developments.
    Labatut AE; Mattheolabakis G
    Eur J Pharm Biopharm; 2018 Jul; 128():82-90. PubMed ID: 29679644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics.
    Gasparello J; Papi C; Zurlo M; Volpi S; Gambari R; Corradini R; Casnati A; Sansone F; Finotti A
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials and Tribulations of MicroRNA Therapeutics.
    Seyhan AA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating microRNAs in cardiac surgery patients: Novel therapeutic opportunities?
    Biglino G; Caputo M; Rajakaruna C; Angelini G; van Rooij E; Emanueli C
    Pharmacol Ther; 2017 Feb; 170():192-204. PubMed ID: 27902930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of microRNA replacement therapy.
    Bader AG; Brown D; Winkler M
    Cancer Res; 2010 Sep; 70(18):7027-30. PubMed ID: 20807816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA nanotherapeutics for cancer.
    Ganju A; Khan S; Hafeez BB; Behrman SW; Yallapu MM; Chauhan SC; Jaggi M
    Drug Discov Today; 2017 Feb; 22(2):424-432. PubMed ID: 27815139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canonical and non-canonical barriers facing antimiR cancer therapeutics.
    Cheng CJ; Saltzman WM; Slack FJ
    Curr Med Chem; 2013; 20(29):3582-93. PubMed ID: 23745563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Trojan-Horse Strategy by
    Kwak G; Kim H; Park J; Kim EH; Jang H; Han G; Wang SY; Yang Y; Chan Kwon I; Kim SH
    ACS Nano; 2021 Jul; 15(7):11369-11384. PubMed ID: 34191497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.